HCPLive Network
  • CMHC 2014
  • CHEST 2014
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Thursday, October 30, 2014
By Gale Scott
The American Academy of Family Physicians is launching a 3-year public relations and lobbying campaign to “tackle issues ranging from payment reform to workforce development,” the organization announced. Discussing the plan at his inaugural address to the AAFM Assembly Oct. 22, Robert Wergin, MD, the group’s new president, said the slogan for the effort will be “Health Is Primary.”
Thursday, October 30, 2014
Women who survive breast cancer face a higher risk of depression that can linger and require antidepressants, according to a new study published online Oct. 27 in the Journal of Clinical Oncology
Thursday, October 30, 2014
Competition between medical practices helps keep health care costs lower, according to a study published in the Oct. 22/29 issue of the Journal of the American Medical Association.
Thursday, October 30, 2014
A new study suggests that high doses of vitamin D may not help prevent the return of bacterial vaginosis. The research was published in the November issue of the American Journal of Obstetrics and Gynecology.
Thursday, October 30, 2014
Frequent readmissions and high inpatient costs are seen among older survivors of in-hospital cardiac arrest, according to a study published online Oct. 28 in Circulation: Cardiovascular Quality and Outcomes
Thursday, October 30, 2014
By Adam Hochron
The new Idiopathic Pulmonary Fibrosis medications that were recently approved will help with treatment for patients but are not a cure for the condition.
Thursday, October 30, 2014
By Adam Hochron
Hypersomnia may not receive the amount of attention as other sleep disorders like sleep apnea, but it affects up to 5% of the population and left untreated can significantly diminish a patient's quality of life.
Thursday, October 30, 2014
By Adam Hochron
The area of sleep study is only around 30 years old but there are still new advancements that can help improve the daily life of a patient.
Thursday, October 30, 2014
By Adam Hochron
As part of the annual meeting of the American College of Chest Physicians new information was rolled out on the "Live Well" Campaign aimed at helping patients with COPD.
Thursday, October 30, 2014
By HCPLive staff
AstraZeneca today announced that the US Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes mellitus.
Thursday, October 30, 2014
Combined biennial digital mammography and tomosynthesis screening is effective for women with dense breasts, according to a study published online Oct. 28 in Radiology.
Wednesday, October 29, 2014
A new small study raises more questions about the accuracy of home blood pressure monitoring devices. The research is scheduled to be presented at the American Society of Nephrology's Kidney Week 2014, held from Nov. 11 to 16 in Philadelphia.
Email Signup
Breaking News
AstraZeneca today announced that the US Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes mellitus.
The US Food and Drug Administration (FDA) today announced the approval of Trumenba, the first vaccine licensed in the US to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B.
Governors in four states have enacted quarantines on health care workers returning from treating Ebola patients in West Africa. The US Centers for Disease Control and Prevention (CDC) says that is not necessary. In interviews with HCPLive’s Gale Scott, two physicians offered sharply different opinions on the states' quarantine policy.
Physician's Money Digest
There have been quite a few hot IPOs this year. Alibaba and GoPro to name just a couple. But the real money was made before these companies even went public.
Medical school enrollment in the US has hit an all-time high, according to data from the Association of American Medical Colleges. The data also show medical schools continue to become more diverse.
Product News
Obizur (Antihemophilic Factor [Recombinant], Porcine Sequence) has been approved to treat acquired hemophilia A (acquired Factor VIII deficiency), a rare, non-inherited form of hemophilia.
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
The US Food and Drug Administration (FDA) has approved the use of an experimental drug to treat patients who have Ebola Virus Disease.
HCPLive Poll
Twitter Advice
Have you ever given medical or financial advice on Twitter?